Riskpilot← Back to searchSign inGet full accessBJERKE TANNMEDISIN AS
ASActiveOrg 987080221Refstadveien 64, 0589 OsloDental practice care activities · NACE 8623Est. 20040 employees
Revenue 2024
NOK 5M
-1% vs 2023
EBITDA margin
19.9%
+8% vs 2023
Equity ratio
53.7%
Financial strength
Net profit 2024
NOK 250K
+34% vs 2023
| Revenue | NOK 5M | -1% |
| EBITDA | NOK 987K | +8% |
| Net profit | NOK 250K | +34% |
| Total assets | NOK 4,3M | +0% |
| Equity | NOK 2,3M | +12% |
| Employees | 0 | — |
Legal name
BJERKE TANNMEDISIN AS
Org number
987080221
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
28. juli 2004
Share capital
NOK 375 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av tannlegeforretning derunder eie og leie lokaler samt å delta i andre selskaper med tilsvarende virksomhet.
Address
Refstadveien 64, 0589 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 273 | 3 900 | 4 108 | 4 997 | 4 950 |
| Staff expenses | −0 | −73 | −87 | −0 | −0 |
| EBITDA | 33 | 926 | 549 | 917 | 987 |
| Depreciation & amort. | −127 | −126 | −129 | −486 | −503 |
| EBIT | −94 | 800 | 420 | 431 | 484 |
| Net financials | 4 | 4 | 3 | −147 | −146 |
| Profit before tax | −90 | 804 | 423 | 284 | 338 |
| Tax | −20 | 177 | 93 | 97 | 87 |
| Net profit | −70 | 627 | 330 | 187 | 250 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 647 | 3 512 | 2 280 | 4 306 | 4 304 |
| Equity | 2 416 | 1 543 | 1 873 | 2 060 | 2 310 |
| Long-term debt | 0 | 0 | 0 | 1 922 | 1 457 |
| Short-term debt | 232 | 1 969 | 407 | 325 | 537 |
| Total debt | 232 | 1 969 | 407 | 2 247 | 1 994 |
EBITDA margin
19.9%
This company
15.8%
Market median
+26% vs market
20202024
Equity ratio
53.7%
This company
38.2%
Market median
+41% vs market
20202024
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20202024
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20202024
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CN Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25.01% | 25.01% | 2024 | |
| Company | 24.96% | 24.96% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Heistein As
BJERKE TANNMEDISIN AS Board members of BJERKE TANNMEDISIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Nyhus | Chief Executive Officer | 0 companies |
| Johan Caspar Wohlfahrt | Board of Directors | 0 companies |
| Andreas Janson | Board of Directors | 0 companies |
| Stig Heistein | Chairman | 0 companies |
| Roy Stefan Samuelsson | Board of Directors | 0 companies |